Categories: Healthcare

3D Cell Culture Technologies Market Commodities, High Growth Opportunities, Segmentation, Market Trends By 2024-2033|Becton Dickinson and Company, Corning Incorporated, Eppendorf AG, GE Healthcare a division of General Electric Company, Merck KGaA

The 3D Cell Culture Technologies Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2011-2022) and extends its insights into a ten-year forecast period (2024-2033).

Learn More On The 3D Cell Culture Technologies Market:

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

According to The Business Research Company’s 3D Cell Culture Technologies Global Market Report 2024, The 3d cell culture technologies market size has grown rapidly in recent years. It will grow from $2.85 billion in 2023 to $3.39 billion in 2024 at a compound annual growth rate (CAGR) of 19.0%. The growth in the historic period can be attributed to advancements in cell biology, drug development, rising incidence of chronic diseases, government funding.

The 3d cell culture technologies market size is expected to see rapid growth in the next few years. It will grow to $6.94 billion in 2028 at a compound annual growth rate (CAGR) of 19.6%. The growth in the forecast period can be attributed to pharmaceutical industry, increasing research and development, environmental and ethical considerations. Major trends in the forecast period include personalized medicine, technological advancements, bioprinting, regenerative medicine.

The increasing requirement for organ transplantation is driving the 3D Cell Culture Technologies Market. 3D cell culture helps in forming a three-dimensional structure which further helps in mimicking the tissue or organ and therefore helps in organ transplantation. 3D cell structures are capable of tissue and organ regeneration as well as providing the provision for drug toxicology screening. For instance, in January 2023, according to United Network for Organ Sharing (UNOS), a US-based non-profit organization, In 2022, 42,887 organ transplants were performed in the United States, an increase of 3.7% over 2021. A total of 14,903 people became deceased organ donors nationwide in 2022, representing the twelfth consecutive record year for deceased donations and an increase of 7.5% over 2021. As the medical criteria for deceased organ donation continue to broaden based on favorable clinical experience, increasing proportions of donors come from less traditional categories of eligibility. In 2022, 4,776 people donated after circulatory death (DCD donors) as opposed to brain death, representing an increase of nearly 14% over the 2021 total. There were 5,789 deceased donors aged 50 or older, the first time there have been more than 5,000 donors of that age range in a single year.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=2462&type=smp

The 3d cell culture technologies market covered in this report is segmented –

1) By Type: Scaffold-based; Scaffold-free; 3D Bioreactors

2) By Application: Cancer Research; Stem Cell Research; Drug Discovery; Regenerative Medicine

3) By End Users: Research Laboratories and Institutes; Biotechnology and Pharmaceutical Companies; Hospitals and Diagnostic Centers; Other End Users

Subsegment: Hydrogels; Polymeric scaffolds; Micropatterned Surface Microplates; Hanging Drop Microplates; Spheroid Microplates; Microfluidic 3D Cell Culture; Magnetic Levitations & 3D Bioprinting

The 3d cell culture technologies market report table of contents includes: